Optimizing Anticoagulation in Atrial Fibrillation: The Role of Clinical Pharmacists in Canadian Practice

Mohamed Abdellatif

Review Article 30 September 2026 Vol. 1, Issue 4

Early Recognition and Management of Sepsis in Hospitalized Adults in Canada: A Contemporary Evidence-Based Review

Judy Zimmerman; Ahmed Tawfiq ; Sara ElSafady; Fourth Author

Review Article 10 September 2026 Vol. 1, Issue 4

Pharmacist-Led Antimicrobial Stewardship Across Canada: Comparing Provincial Models for Hospitals With Limited Infectious Diseases Resources

Mohamed Abdellatif

Review Article 12 August 2026 Vol. 1, Issue 3

Management of Resistant Hypertension in Canada: Physician and Clinical Pharmacist Perspectives Across Ambulatory and Hospital Care

Francis Stewart, Jacob Deeman, Mohamed Abdellatif

Review Article 26 July 2026 Vol. 1, Issue 2

Guideline Concordance for HFrEF Therapy in the United Arab Emirates: Retrospective Real-World Data Benchmarked Against Canadian Practice

Judy Zimmerman , Ahmed Tawfiq, Sara ElSafady

Review Article 10 July 2026 Vol. 1, Issue 2

Anticoagulation in Older Adults With Advanced Chronic Kidney Disease and Atrial Fibrillation: Comparative Safety of Apixaban, Rivaroxaban, and Warfarin

MOHAMED ABDELLATIF

Review Article 10 July 2026 Vol. 1, Issue 2

SGLT2 Inhibitors and GLP-1 Receptor Agonists in Cardiorenal-Metabolic Syndrome: Canadian Evidence, Mechanistic Complementarity, and Pharmacotherapeutic Strategies

MOHAMED ABDELLATIF

Review Article 1 July 2026 Vol. 1, Issue 1

Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy: Canadian Practice and the Transition to Model-Informed Precision Dosing

Mohamed Abdellatif

Review Article 18 June 2026 Vol. 1, Issue 1

Clinical Pharmacist Interventions for Medication Adherence and Glycemic Control in Type 2 Diabetes: Lessons From Canadian Health Systems

Mohamed Abdellatif

Review Article 1 June 2026 Vol. 1, Issue 1